Full Title
A Phase I Trial for R/R MetAstatic DLL3+ Cancers utilizing Armored CAR T cells (ARMADA)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Adam Schoenfeld’s office at 646-608-4042.
Protocol
26-062
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Co-Investigators
Locations
ClinicalTrials.gov ID
NCT07783477
ClinicalTrials.gov